ÐÂÎÅ×ÊѶ
ÄÐÐÔµÄÇ¿Ê¢£¬ £¬£¬£¬ £¬£¬£¬£¬ÔÚÓÚ´ÓÈÝ¡ª¡ª¡ªÏ²±¨£¡º£ÄÚÊ׸ö£¡Î÷°àÑÀÔÑÐÈë¿ÚèÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº»ñÅúÉÏÊУ¡
ÈÕÆÚ£º
2026Äê04ÔÂ03ÈÕ 14:35
èÛéÚËáÎ÷µØÄÇ·Ç¿Ú·þ»ìÐüÒº£¨ÐÒ·ö½¡®£©ÉÏÊÐÉêÇëÕýʽ»ñÅú¡£¡£¡£¡£¡£¡£¡£¡£×÷Ϊº£ÄÚÊ׸ö¿Ú·þ»ìÐüÒº¼ÁÐ͵ÄÎ÷µØÄÇ·Ç£¬ £¬£¬£¬ £¬£¬£¬£¬Õâ¿îÓÉÎ÷°àÑÀÔÑÐÉú²úµÄ²úÆ·£¬ £¬£¬£¬ £¬£¬£¬£¬²»µ«Ìî²¹ÁËED£¨²ªÆð¹¦Ð§ÕÏ°£©ÖÎÁÆÁìÓòµÄ¼ÁÐÍ¿Õȱ£¬ £¬£¬£¬ £¬£¬£¬£¬¸ü±ê¼Ç×ÅÄÐÐÔ¿µ½¡ÖÎÀíÂõÈëÁ˾«×¼¿ØÁ¿¡¢ÌåÑéÓÅÏȵÄн׶Ρ£¡£¡£¡£¡£¡£¡£¡£Ëü¼È·ÇÈ«ÐÂÒòËØ£¬ £¬£¬£¬ £¬£¬£¬£¬Ò²·ÇÊ׷£¬ £¬£¬£¬ £¬£¬£¬£¬¶øÊÇÖ±»÷»¼Õßδ±»Öª×ãµÄÓÃÒ©ÐèÇó£¬ £¬£¬£¬ £¬£¬£¬£¬ÒÔ¸ÄÁ¼ÐÍÐÂÒ©µÄ×Ë̬£¬ £¬£¬£¬ £¬£¬£¬£¬ÖØнç˵·þÒ©ÌåÑé——¸üÓÐÓ㬠£¬£¬£¬ £¬£¬£¬£¬¸üÌåÃ棬 £¬£¬£¬ £¬£¬£¬£¬¸ü´ÓÈÝ¡£¡£¡£¡£¡£¡£¡£¡£
Ò»¡¢Êг¡ÏÖ×´£ºEDÖÎÁÆÐèÇóÏÔÖø£¬ £¬£¬£¬ £¬£¬£¬£¬¹Å°åÓÃÒ©Í´µãÈÔ´æ
Ïֽ׶Î,EDÒѳÉΪӰÏìÄÐÐÔÉúÑÄÖÊÁ¿µÄÖ÷ÒªÎÊÌâÖ®Ò»¡£¡£¡£¡£¡£¡£¡£¡£ÔÚÎÒ¹úÓÐ×ÅÖØ´óµÄ»¼Õß»ùÊý¡£¡£¡£¡£¡£¡£¡£¡£¾Ý¹ûÕæÊý¾ÝÏÔʾ£¬ £¬£¬£¬ £¬£¬£¬£¬ÎÒ¹úED»¼ÕßÈËÊýÔ¼1.4ÒÚÈË¡£¡£¡£¡£¡£¡£¡£¡£¾Ý¡¶2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé¡·ÏÔʾ£¬ £¬£¬£¬ £¬£¬£¬£¬31-40ËêÄÐÐÔÕ¼±È44.79%£¬ £¬£¬£¬ £¬£¬£¬£¬21-30ËêȺÌåÒ²µÖ´ï38.03%£¬ £¬£¬£¬ £¬£¬£¬£¬·ºÆðÄêÇữÇ÷ÊÆ¡£¡£¡£¡£¡£¡£¡£¡£
´ÓÊг¡¹æÄ£À´¿´£¬ £¬£¬£¬ £¬£¬£¬£¬EDÒ©ÎïÈüµÀÌåÁ¿¿É¹Û£¬ £¬£¬£¬ £¬£¬£¬£¬¶øÎ÷µØÄÇ·ÇÔÚËùÓÐEDÀàÒ©ÎïÊг¡Õ¼±È¶ÀÙÆ°ÁÍ·£¬ £¬£¬£¬ £¬£¬£¬£¬2024ÄêÕ¼±È¸ß´ï71.96%¡£¡£¡£¡£¡£¡£¡£¡£×÷ΪPDE5ÒÖÖƼÁµÄ½¹µãÆ·À࣬ £¬£¬£¬ £¬£¬£¬£¬Î÷µØÄǷǸüÊDZ»º£ÄÚÍâ¶àÏîȨÍþÖ¸ÄÏ£¨È硶²ªÆð¹¦Ð§ÕÏ°Õï¶ÏÓëÖÎÁÆÖ¸ÄÏ¡·¡¶Å·ÖÞÃÚÄòѧ»áÐÔÓëÉúÖ³¿µ½¡Ö¸ÄÏ¡·µÈ£©ÁÐΪEDÖÎÁƵÄÊ×Ñ¡Ò©Î £¬£¬£¬ £¬£¬£¬£¬ÆäÓÐÓÃÐÔÓëÇå¾²ÐÔÒÑ»ñµÃÆÕ±éÑéÖ¤¡£¡£¡£¡£¡£¡£¡£¡£
Ö»¹Ü¿Ú·þPDE5ÒÖÖƼÁÊÇEDÖÎÁƵÄÖ÷Á÷Ñ¡Ôñ£¬ £¬£¬£¬ £¬£¬£¬£¬ÇÒ38.64%µÄÄÐÐÔÔø·þÓùý¿¹EDÒ©Îï1£¬ £¬£¬£¬ £¬£¬£¬£¬µ«¹Å°åƬ¼ÁµÄÍ´µãʼÖÕÄÑÒÔ½â¾ö£¬ £¬£¬£¬ £¬£¬£¬£¬³ÉΪ»¼ÕßÓÃÒ©µÄÒþÐÎÃż÷£º
¼ÁÁ¿Àο¿£ºÏÖÓе¥ºÐ°ü×°¼ÁÐͼÁÁ¿¾ùÒÑÀο¿£¬ £¬£¬£¬ £¬£¬£¬£¬ÎÞ·¨Æ¥Åä¸öÌ廯ÐèÇó £»£» £»£»£»£»£»£»
ÐèË®ËÍ·þ£ºÎÞ·¨Öª×ãÎÞË®Ìõ¼þÏÂËæʱËæµØÔ½·¢±ã½Ý¸øÒ© £»£» £»£»£»£»£»£»
Òþ˽ÞÏÞΣºÒ©Æ¬°ü×°Ò×̻¶Òþ˽£¬ £¬£¬£¬ £¬£¬£¬£¬ÓÈÆäÔÚÉç½»³¡¾°ÏÂÓÃÒ©±ãµ±ÐÔ´ó·ùϽµ £»£» £»£»£»£»£»£»
ÍÌÑÊÕÏ°£ºÔ¼40.2£¥µÄÄÐÐÔ±£´æÍÌÑÊÄÑÌâ2£¬ £¬£¬£¬ £¬£¬£¬£¬Æ¬¼ÁÄÑÒÔÖª×ãÍÌÑÊÕÏ°ÕßÓÃÒ©ÐèÇ󡣡£¡£¡£¡£¡£¡£¡£
¶þ¡¢ÐÒ·ö½¡®£ºÒÔ¸ÄÁ¼ÊµÏÖÌåÑéÉý¼¶¾«×¼»÷ÖÐÁÙ´²Í´µã
ÐÒ·ö½¡®µÄÉÏÊУ¬ £¬£¬£¬ £¬£¬£¬£¬ÕýÊǶÔÕâËÄ´óÍ´µãµÄ¾«×¼»ØÓ¦£º
¾«×¼¼ÁÁ¿¶¨ÖÆ£º¼ÁÁ¿¿Éƾ֤ÐèÇóÎÞаµ÷Àí£¬ £¬£¬£¬ £¬£¬£¬£¬25-100mg×ÔÓɵ÷½â£¬ £¬£¬£¬ £¬£¬£¬£¬Æ¥Åä¸öÐÔ»¯ÐèÇó £»£» £»£»£»£»£»£»
ʹÓÃÀû±ã¿ì½Ý£ºÎ¢·Û»¯Êèɢϵͳ£¬ £¬£¬£¬ £¬£¬£¬£¬ÎÞÐèË®ËÍ·þ£¬ £¬£¬£¬ £¬£¬£¬£¬ËæʱËæµØÍê³É¸øÒ©£¬ £¬£¬£¬ £¬£¬£¬£¬ÊÊÅä¶àÔªÉúÑij¡¾° £»£» £»£»£»£»£»£»
È«ÐÂÓÃÒ©ÌåÑ飺°Ñ“͵͵ÃþÃþÍÌƬ”Éý¼¶Îª“×Æ˸Õý´ó¿ÚÅç¸øÒ©”£¬ £¬£¬£¬ £¬£¬£¬£¬½â¾öÉç½»³¡¾°µÄÒþ˽ÞÏÞΡ£¡£¡£¡£¡£¡£¡£¡£
ÊÊÓÃÈËȺÆձ飺ÌØÊâÊʺÏÍÌÑÊÄÑÌâ¡¢Ðè׼ȷ¼ÁÁ¿µ÷½âµÄʹÓÃÕß
Èý¡¢´Ó“ÓÐÓÔµ½“ºÃÓÔ£ºÒ»³¡¹ØÓÚ·þÒ©ÌåÑéµÄÀíÄî¸ïÃü
ÐÒ·ö½¡®µÄ»ñÅú£¬ £¬£¬£¬ £¬£¬£¬£¬Ô¶·ÇÒ»´Î¼òÆӵļÁÐ͸ÄÁ¼£¬ £¬£¬£¬ £¬£¬£¬£¬¶øÊÇÒ»³¡¹ØÓÚEDÖÎÁƵÄÀíÄî¸ïÃü——ÎÒÃÇÕýÔÚÖØнç˵ʲô²ÅÊÇ“ºÃÒ©”¡£¡£¡£¡£¡£¡£¡£¡£
ºã¾ÃÒÔÀ´£¬ £¬£¬£¬ £¬£¬£¬£¬Ò½Ò©ÐÐÒµÖ´×ÅÓÚ×·ÇóÒ©ÎïµÄ“ÓÐÓÃÐÔ”£¬ £¬£¬£¬ £¬£¬£¬£¬È´ÍùÍùºöÂÔÁË“¿ÉÓÃÐÔ”¡£¡£¡£¡£¡£¡£¡£¡£µ±»¼ÕßÐèÒªêþҩƬ¡¢ÕÒË®±¡¢ÅÌËãʱ¼ä¡¢ÌÓ±ÜÑÛ¹âʱ£¬ £¬£¬£¬ £¬£¬£¬£¬Ò©ÎïµÄÁÆЧÒÑÔÚ²ã²ãÕÛËðÖдòÁËÕÛ¿Û¡£¡£¡£¡£¡£¡£¡£¡£
ÐÒ·ö½¡®µÄ·ºÆ𣬠£¬£¬£¬ £¬£¬£¬£¬±ê¼Ç×ÅEDÖÎÁÆÕýʽ´Ó“·þÒ©Öβ¡”µÄ1.0ʱ´ú£¬ £¬£¬£¬ £¬£¬£¬£¬ÂõÈë“ÌåÑéÓÅÏÈ”µÄ2.0ʱ´ú¡£¡£¡£¡£¡£¡£¡£¡£Õâ²»µ«ÊÇÊÖÒÕµÄÇ°½ø£¬ £¬£¬£¬ £¬£¬£¬£¬¸üÊǼÛÖµ¹ÛµÄת±ä£º
-
´Ó“»¼Õß˳ӦҩÎ½“Ò©Îï˳Ӧ»¼Õß”
-
´Ó“¼òµ¥¼ÁÁ¿”µ½“¸öÐÔ»¯¼Æ»®”
-
´Ó“Ò½ÁƳ¡¾°”µ½“ÉúÑij¡¾°”
-
´Ó“Öβ¡”µ½“ÖÎÐÄ”
“¸úÓÐÇéÈË×ö¿ìÀÖÊ£¬ £¬£¬£¬ £¬£¬£¬£¬±ðÎÊÊǽÙÊÇÔµ¡£¡£¡£¡£¡£¡£¡£¡£”Õâ¾äÀ´×Ô¡¶Á÷¹â°¿Ïè¡·µÄ¸è´Ê£¬ £¬£¬£¬ £¬£¬£¬£¬µÀ¾¡ÁËÈËÊÀÇé°®µÄ´¿´âÓëäìÈ÷¡£¡£¡£¡£¡£¡£¡£¡£¶øÒ»·Ý´ÓÈݵĵ×Æø£¬ £¬£¬£¬ £¬£¬£¬£¬ÕýÊÇÕâ“¿ìÀÖÊ”×îºÃµÄ×îÏÈ¡£¡£¡£¡£¡£¡£¡£¡£
ÏÖÔÚ£¬ £¬£¬£¬ £¬£¬£¬£¬ÐÒ·ö½¡® ÔÚÒ½Ò©ÁìÓòÕÒµ½ÁËеÄ×¢½Å——ÕæÕýµÄÖÎÁÆ£¬ £¬£¬£¬ £¬£¬£¬£¬Ó¦µ±Èû¼ÕßÔÚ×·Çó¿µ½¡µÄõ辶ÉÏ£¬ £¬£¬£¬ £¬£¬£¬£¬±£ÓÐÓ¦ÓеĴÓÈÝÓëÌåÃæ¡£¡£¡£¡£¡£¡£¡£¡£
ÎÒÃÇÆÚ´ýÓë¸÷½çЯÊÖ£¬ £¬£¬£¬ £¬£¬£¬£¬ÈÃÕⳡʼÓÚ¼ÁÐ͵ÄÀå¸ï£¬ £¬£¬£¬ £¬£¬£¬£¬×îÖÕÒý·¢Õû¸öÐÐÒµ¶Ô»¼ÕßÌåÑéµÄÖØйØ×¢¡£¡£¡£¡£¡£¡£¡£¡£ÓÉÓÚ£¬ £¬£¬£¬ £¬£¬£¬£¬×îºÃµÄÒ©£¬ £¬£¬£¬ £¬£¬£¬£¬²»µ«ÊÇÄÜÈò¡ÈËȬÓúµÄÒ©£¬ £¬£¬£¬ £¬£¬£¬£¬¸üÊÇÈò¡ÈËÔ¸Òâ¼á³Ö·þÓõÄÒ©¡£¡£¡£¡£¡£¡£¡£¡£
×ÊÁÏȪԴ
1¡¢2024ÄêÖйú¿¹EDÒ©ÎïÐÐÒµ°×ƤÊé
2¡¢Pharmacokinetic Parameters of a Novel SildenafiOral Liquid Suspension Administered to HealthyAdult Men Under Fasted Conditions
3¡¢ÖйúÌض¨ÈËȺÍÌÑʹ¦Ð§ÕÏ°µÄÊ¢Ðв¡Ñ§ÊӲ챨¸æ.ÖлªÎïÀíҽѧÓ뿵ÅÓºêÔ¸2017Äê12ÔµÚ39¾íµÚ12ÆÚ
4¡¢Ã×ÄÚÍøÊý¾Ý¿â¡¢²úÆ·ÁÙ´²Ñо¿Êý¾Ý
Ïà¹ØÍƼö
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ